One major player, venture backed-Biovitrum, which first sold shares to the public on the Stockholm Exchange in 2006, develops drugs to treat diseases including hemophilia, glaucoma and diabetes.

FORBES: Venture Investing, Euro-Style

All you do is send in a cheek swab with DNA on it, and a few weeks later a variety of gene data will be posted on the Web, including whether you have genes recently discovered to be associated with risk for heart attacks, macular degeneration, glaucoma, diabetes, prostate cancer, breast cancer and a variety of other diseases (see: www.decodeme.com).

FORBES: Personal Genome Race Goes Into Overdrive